APO Research
Talk to an analyst

APO RESEARCH · REPORT

Smart Therapies

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Smart Therapies Market Analysis and Forecast 2026-2032

12 August 2026173 pages

Choose your research edition.

Industry ResearchSmart Therapies Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Smart Therapies Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Smart Therapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Smart Therapies Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Smart Therapies Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global Smart Therapies market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Smart Therapies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Smart Therapies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Smart Therapies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Smart Therapies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Smart Therapies include Microsot Healthcare, Tempus, Flatiron Health, 23andMe, Verly Life Sciences, Roche, IBM Watson Health, Google Health and Amazon Web Services (AWS) Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Smart Therapies, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Smart Therapies, also provides the revenue of main regions and countries. Of the upcoming market potential for Smart Therapies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Smart Therapies revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Smart Therapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Smart Therapies revenue, projected growth trends, production technology, application and end-user industry.

Smart Therapies Segment by Company

Microsot Healthcare

Tempus

Flatiron Health

23andMe

Verly Life Sciences

Roche

IBM Watson Health

Google Health

Amazon Web Services (AWS) Healthcare

Smart Therapies Segment by Type

Artificial Intelligence

Machine Learning

Digital Health Tools

Others

Smart Therapies Segment by Application

Hospitals & Clinics

Pharmaceutical Companies

Research Institutions

Smart Therapies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Smart Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Smart Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Smart Therapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Smart Therapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Smart Therapies company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Smart Therapies revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Smart Therapies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Artificial Intelligence Major Player Table 3. Machine Learning Major Player Table 4. Digital Health Tools Major Player Table 5. Others Major Player Table 6. Global Smart Therapies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals & Clinics Major Player Table 8. Pharmaceutical Companies Major Player Table 9. Research Institutions Major Player Table 10. Smart Therapies Industry Trends Table 11. Smart Therapies Industry Drivers Table 12. Smart Therapies Industry Opportunities and Challenges Table 13. Smart Therapies Industry Restraints Table 14. Global Smart Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Smart Therapies Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Smart Therapies Market Share by Region (2021-2026) Table 17. Global Smart Therapies Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Smart Therapies Market Share by Region (2027-2032) Table 19. Global Smart Therapies Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Smart Therapies Revenue Market Share by Players (2021-2026) Table 21. Global Smart Therapies Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Smart Therapies Key Players Headquarters & Area Served Table 23. Global Smart Therapies Players, Product Type & Application Table 24. Global Smart Therapies Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Smart Therapies by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Smart Therapies Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Smart Therapies Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Smart Therapies Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Smart Therapies Revenue Market Share by Type (2021-2026) Table 31. Global Smart Therapies Revenue Market Share by Type (2027-2032) Table 32. Global Smart Therapies Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Smart Therapies Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Smart Therapies Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Smart Therapies Revenue Market Share by Application (2021-2026) Table 36. Global Smart Therapies Revenue Market Share by Application (2027-2032) Table 37. Microsot Healthcare Company Information Table 38. Microsot Healthcare Business Overview Table 39. Microsot Healthcare Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Microsot Healthcare Smart Therapies Product Portfolio Table 41. Microsot Healthcare Recent Development Table 42. Tempus Company Information Table 43. Tempus Business Overview Table 44. Tempus Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Tempus Smart Therapies Product Portfolio Table 46. Tempus Recent Development Table 47. Flatiron Health Company Information Table 48. Flatiron Health Business Overview Table 49. Flatiron Health Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Flatiron Health Smart Therapies Product Portfolio Table 51. Flatiron Health Recent Development Table 52. 23andMe Company Information Table 53. 23andMe Business Overview Table 54. 23andMe Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. 23andMe Smart Therapies Product Portfolio Table 56. 23andMe Recent Development Table 57. Verly Life Sciences Company Information Table 58. Verly Life Sciences Business Overview Table 59. Verly Life Sciences Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Verly Life Sciences Smart Therapies Product Portfolio Table 61. Verly Life Sciences Recent Development Table 62. Roche Company Information Table 63. Roche Business Overview Table 64. Roche Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Roche Smart Therapies Product Portfolio Table 66. Roche Recent Development Table 67. IBM Watson Health Company Information Table 68. IBM Watson Health Business Overview Table 69. IBM Watson Health Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. IBM Watson Health Smart Therapies Product Portfolio Table 71. IBM Watson Health Recent Development Table 72. Google Health Company Information Table 73. Google Health Business Overview Table 74. Google Health Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Google Health Smart Therapies Product Portfolio Table 76. Google Health Recent Development Table 77. Amazon Web Services (AWS) Healthcare Company Information Table 78. Amazon Web Services (AWS) Healthcare Business Overview Table 79. Amazon Web Services (AWS) Healthcare Smart Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Amazon Web Services (AWS) Healthcare Smart Therapies Product Portfolio Table 81. Amazon Web Services (AWS) Healthcare Recent Development Table 82. North America Smart Therapies Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Smart Therapies Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Smart Therapies Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Smart Therapies Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Smart Therapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Smart Therapies Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Smart Therapies Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Smart Therapies Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Smart Therapies Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Smart Therapies Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Smart Therapies Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Smart Therapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Smart Therapies Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Smart Therapies Revenue by Country (US$ Million) & (2027-2032) Table 96. China Smart Therapies Revenue by Type (2021-2026) & (US$ Million) Table 97. China Smart Therapies Revenue by Type (2027-2032) & (US$ Million) Table 98. China Smart Therapies Revenue by Application (2021-2026) & (US$ Million) Table 99. China Smart Therapies Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Smart Therapies Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Smart Therapies Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Smart Therapies Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Smart Therapies Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Smart Therapies Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Smart Therapies Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Smart Therapies Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Smart Therapies Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Smart Therapies Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Smart Therapies Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Smart Therapies Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Smart Therapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Smart Therapies Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Smart Therapies Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Smart Therapies Image Figure 2. Global Smart Therapies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Smart Therapies Market Size Share 2021 VS 2025 VS 2032 Figure 4. Artificial Intelligence Image Figure 5. Machine Learning Image Figure 6. Digital Health Tools Image Figure 7. Others Image Figure 8. Global Smart Therapies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Smart Therapies Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals & Clinics Image Figure 11. Pharmaceutical Companies Image Figure 12. Research Institutions Image Figure 13. Global Smart Therapies Market Size (US$ Million) & (2021-2032) Figure 14. Global Smart Therapies Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Smart Therapies Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Smart Therapies Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Smart Therapies Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Smart Therapies Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Smart Therapies Revenue Market Share by Type (2021-2032) Figure 21. Global Smart Therapies Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Smart Therapies Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Smart Therapies Revenue Market Share by Application (2021-2032) Figure 24. North America Smart Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Smart Therapies Revenue Share by Type (2021-2032) Figure 26. North America Smart Therapies Revenue Share by Application (2021-2032) Figure 27. North America Smart Therapies Revenue Share by Country (2021-2032) Figure 28. United States Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Smart Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Smart Therapies Revenue Share by Type (2021-2032) Figure 33. Europe Smart Therapies Revenue Share by Application (2021-2032) Figure 34. Europe Smart Therapies Revenue Share by Country (2021-2032) Figure 35. Germany Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Smart Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Smart Therapies Revenue Share by Type (2021-2032) Figure 45. China Smart Therapies Revenue Share by Application (2021-2032) Figure 46. Asia Smart Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Smart Therapies Revenue Share by Type (2021-2032) Figure 48. Asia Smart Therapies Revenue Share by Application (2021-2032) Figure 49. Asia Smart Therapies Revenue Share by Region (2021-2032) Figure 50. Japan Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Smart Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Smart Therapies Revenue Share by Type (2021-2032) Figure 58. SAMEA Smart Therapies Revenue Share by Application (2021-2032) Figure 59. SAMEA Smart Therapies Revenue Share by Country (2021-2032) Figure 60. Brazil Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Smart Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Artificial Intelligence
  • Machine Learning
  • Digital Health Tools
  • Others
Applications
  • Hospitals & Clinics
  • Pharmaceutical Companies
  • Research Institutions
Companies covered
  • Microsot Healthcare
  • Tempus
  • Flatiron Health
  • 23andMe
  • Verly Life Sciences
  • Roche
  • IBM Watson Health
  • Google Health
  • Amazon Web Services (AWS) Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Smart Therapies Market by Type
  3. 1.2.1 Global Smart Therapies Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Artificial Intelligence
  5. 1.2.3 Machine Learning
  6. 1.2.4 Digital Health Tools
  7. 1.2.5 Others
  8. 1.3 Smart Therapies Market by Application
  9. 1.3.1 Global Smart Therapies Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals & Clinics
  11. 1.3.3 Pharmaceutical Companies
  12. 1.3.4 Research Institutions
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Smart Therapies Market Dynamics
  1. 2.1 Smart Therapies Industry Trends
  2. 2.2 Smart Therapies Industry Drivers
  3. 2.3 Smart Therapies Industry Opportunities and Challenges
  4. 2.4 Smart Therapies Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Smart Therapies Market Perspective (2021-2032)
  2. 3.2 Global Smart Therapies Growth Trends by Region
  3. 3.2.1 Global Smart Therapies Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Smart Therapies Market Size by Region (2021-2026)
  5. 3.2.3 Global Smart Therapies Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Smart Therapies Revenue by Players
  2. 4.1.1 Global Smart Therapies Revenue by Players (2021-2026)
  3. 4.1.2 Global Smart Therapies Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Smart Therapies Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Smart Therapies Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Smart Therapies Key Players Headquarters & Area Served
  7. 4.4 Global Smart Therapies Players, Product Type & Application
  8. 4.5 Global Smart Therapies Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Smart Therapies Market CR5 and HHI
  11. 4.6.3 2025 Smart Therapies Tier 1, Tier 2, and Tier 3
5 Smart Therapies Market Size by Type
  1. 5.1 Global Smart Therapies Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Smart Therapies Revenue by Type (2021-2032)
  3. 5.3 Global Smart Therapies Revenue Market Share by Type (2021-2032)
6 Smart Therapies Market Size by Application
  1. 6.1 Global Smart Therapies Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Smart Therapies Revenue by Application (2021-2032)
  3. 6.3 Global Smart Therapies Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Microsot Healthcare
  2. 7.1.1 Microsot Healthcare Company Information
  3. 7.1.2 Microsot Healthcare Business Overview
  4. 7.1.3 Microsot Healthcare Smart Therapies Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Microsot Healthcare Smart Therapies Product Portfolio
  6. 7.1.5 Microsot Healthcare Recent Developments
  7. 7.2 Tempus
  8. 7.2.1 Tempus Company Information
  9. 7.2.2 Tempus Business Overview
  10. 7.2.3 Tempus Smart Therapies Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Tempus Smart Therapies Product Portfolio
  12. 7.2.5 Tempus Recent Developments
  13. 7.3 Flatiron Health
  14. 7.3.1 Flatiron Health Company Information
  15. 7.3.2 Flatiron Health Business Overview
  16. 7.3.3 Flatiron Health Smart Therapies Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Flatiron Health Smart Therapies Product Portfolio
  18. 7.3.5 Flatiron Health Recent Developments
  19. 7.4 23andMe
  20. 7.4.1 23andMe Company Information
  21. 7.4.2 23andMe Business Overview
  22. 7.4.3 23andMe Smart Therapies Revenue and Gross Margin (2021-2026)
  23. 7.4.4 23andMe Smart Therapies Product Portfolio
  24. 7.4.5 23andMe Recent Developments
  25. 7.5 Verly Life Sciences
  26. 7.5.1 Verly Life Sciences Company Information
  27. 7.5.2 Verly Life Sciences Business Overview
  28. 7.5.3 Verly Life Sciences Smart Therapies Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Verly Life Sciences Smart Therapies Product Portfolio
  30. 7.5.5 Verly Life Sciences Recent Developments
  31. 7.6 Roche
  32. 7.6.1 Roche Company Information
  33. 7.6.2 Roche Business Overview
  34. 7.6.3 Roche Smart Therapies Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Roche Smart Therapies Product Portfolio
  36. 7.6.5 Roche Recent Developments
  37. 7.7 IBM Watson Health
  38. 7.7.1 IBM Watson Health Company Information
  39. 7.7.2 IBM Watson Health Business Overview
  40. 7.7.3 IBM Watson Health Smart Therapies Revenue and Gross Margin (2021-2026)
  41. 7.7.4 IBM Watson Health Smart Therapies Product Portfolio
  42. 7.7.5 IBM Watson Health Recent Developments
  43. 7.8 Google Health
  44. 7.8.1 Google Health Company Information
  45. 7.8.2 Google Health Business Overview
  46. 7.8.3 Google Health Smart Therapies Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Google Health Smart Therapies Product Portfolio
  48. 7.8.5 Google Health Recent Developments
  49. 7.9 Amazon Web Services (AWS) Healthcare
  50. 7.9.1 Amazon Web Services (AWS) Healthcare Company Information
  51. 7.9.2 Amazon Web Services (AWS) Healthcare Business Overview
  52. 7.9.3 Amazon Web Services (AWS) Healthcare Smart Therapies Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Amazon Web Services (AWS) Healthcare Smart Therapies Product Portfolio
  54. 7.9.5 Amazon Web Services (AWS) Healthcare Recent Developments
8 North America
  1. 8.1 North America Smart Therapies Revenue (2021-2032)
  2. 8.2 North America Smart Therapies Revenue by Type (2021-2032)
  3. 8.2.1 North America Smart Therapies Revenue by Type (2021-2026)
  4. 8.2.2 North America Smart Therapies Revenue by Type (2027-2032)
  5. 8.3 North America Smart Therapies Revenue Share by Type (2021-2032)
  6. 8.4 North America Smart Therapies Revenue by Application (2021-2032)
  7. 8.4.1 North America Smart Therapies Revenue by Application (2021-2026)
  8. 8.4.2 North America Smart Therapies Revenue by Application (2027-2032)
  9. 8.5 North America Smart Therapies Revenue Share by Application (2021-2032)
  10. 8.6 North America Smart Therapies Revenue by Country
  11. 8.6.1 North America Smart Therapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Smart Therapies Revenue by Country (2021-2026)
  13. 8.6.3 North America Smart Therapies Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Smart Therapies Revenue (2021-2032)
  2. 9.2 Europe Smart Therapies Revenue by Type (2021-2032)
  3. 9.2.1 Europe Smart Therapies Revenue by Type (2021-2026)
  4. 9.2.2 Europe Smart Therapies Revenue by Type (2027-2032)
  5. 9.3 Europe Smart Therapies Revenue Share by Type (2021-2032)
  6. 9.4 Europe Smart Therapies Revenue by Application (2021-2032)
  7. 9.4.1 Europe Smart Therapies Revenue by Application (2021-2026)
  8. 9.4.2 Europe Smart Therapies Revenue by Application (2027-2032)
  9. 9.5 Europe Smart Therapies Revenue Share by Application (2021-2032)
  10. 9.6 Europe Smart Therapies Revenue by Country
  11. 9.6.1 Europe Smart Therapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Smart Therapies Revenue by Country (2021-2026)
  13. 9.6.3 Europe Smart Therapies Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Smart Therapies Revenue (2021-2032)
  2. 10.2 China Smart Therapies Revenue by Type (2021-2032)
  3. 10.2.1 China Smart Therapies Revenue by Type (2021-2026)
  4. 10.2.2 China Smart Therapies Revenue by Type (2027-2032)
  5. 10.3 China Smart Therapies Revenue Share by Type (2021-2032)
  6. 10.4 China Smart Therapies Revenue by Application (2021-2032)
  7. 10.4.1 China Smart Therapies Revenue by Application (2021-2026)
  8. 10.4.2 China Smart Therapies Revenue by Application (2027-2032)
  9. 10.5 China Smart Therapies Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Smart Therapies Revenue (2021-2032)
  2. 11.2 Asia Smart Therapies Revenue by Type (2021-2032)
  3. 11.2.1 Asia Smart Therapies Revenue by Type (2021-2026)
  4. 11.2.2 Asia Smart Therapies Revenue by Type (2027-2032)
  5. 11.3 Asia Smart Therapies Revenue Share by Type (2021-2032)
  6. 11.4 Asia Smart Therapies Revenue by Application (2021-2032)
  7. 11.4.1 Asia Smart Therapies Revenue by Application (2021-2026)
  8. 11.4.2 Asia Smart Therapies Revenue by Application (2027-2032)
  9. 11.5 Asia Smart Therapies Revenue Share by Application (2021-2032)
  10. 11.6 Asia Smart Therapies Revenue by Country
  11. 11.6.1 Asia Smart Therapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Smart Therapies Revenue by Country (2021-2026)
  13. 11.6.3 Asia Smart Therapies Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Smart Therapies Revenue (2021-2032)
  2. 12.2 SAMEA Smart Therapies Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Smart Therapies Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Smart Therapies Revenue by Type (2027-2032)
  5. 12.3 SAMEA Smart Therapies Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Smart Therapies Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Smart Therapies Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Smart Therapies Revenue by Application (2027-2032)
  9. 12.5 SAMEA Smart Therapies Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Smart Therapies Revenue by Country
  11. 12.6.1 SAMEA Smart Therapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Smart Therapies Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Smart Therapies Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst